Evaluating the Role of Basiliximab Induction in Simultaneous Liver–Kidney Transplantation: A Multicenter Propensity-Score-Matched Analysis
SLK recipients without basiliximab induction had comparable rejection outcomes but more viral infections, potentially from greater steroid exposure, and more liver biopsies, which may reflect higher clinical suspicion for rejection or incomplete capture of rejection events in EMR data.
Authors
- Alfred S. Lea (ORCID: https://orcid.org/0000-0002-5527-7707)
- T. Engebretsen
- Daniel Arango
- Michael Kueht (ORCID: https://orcid.org/0000-0003-2509-0877)
- Heather L. Stevenson (ORCID: https://orcid.org/0000-0002-0645-7621)
- Avery Koi
Institutions
- The University of Texas Medical Branch at Galveston (US)
Publication Details
- Journal
- Antibodies
- Published
- 2025-10-28
- DOI
- https://doi.org/10.3390/antib14040091
- Primary Topic
- Organ Transplantation Techniques and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00